Association between the BDNF Val66Met polymorphism and major depressive disorder: a systematic review and meta-analysis
Frontiers in Psychiatry · 21.06.2023 · 14
DOI: 10.3389/fpsyt.2023.1143833 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Psychiatry, online erschienen am 21.06.2023. Verfasst von Yuxia Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mental Diseases, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shan…. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Study objectives This meta-analysis analytically reviewed recent studies concerning the potential associations between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and susceptibility to major depressive disorder (MDD), with subgroup analyses for race and age.
Methods
Relevant case-control studies were systematically searched for in PubMed, Embase, the Web of Science, China National Knowledge Infrastructure (CNKI), Wanfang, and Sinomed databases. A total of 24 studies were finally identified to have reported outcomes including alleles, dominant genes, recessive genes, homozygosity, and heterozygosity. Subgroup meta-analyses were performed based on participant age and ethnicity. Publication bias was represented by funnel plots. All meta-analyses of the randomized controlled trials included for evaluation were performed using RevMan5.3 software.
Results
The findings revealed no significant association between BDNF Val66Met polymorphism and MDD. However, the Met allele was found to be associated with genetic susceptibility to MDD among white populations on subgroup analysis (OR = 1.25, 95% CI: 1.05–1.48, P = 0.01). In the genetic model, dominant (OR = 1.40, 95% CI: 1.18–1.66, P = 0.0001), recessive (OR = 1.70, 95% CI: 1.05–2.78, P = 0.03), and homozygous (OR = 1.77, 95% CI: 1.08–2.88, P = 0.02) genes were all associated with MDD.
Conclusions
Despite the outcome limitations, this meta-analysis confirmed that the BDNF Val66Met polymorphism is a susceptibility factor for MDD in white populations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Mental Diseases, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Zitieren
APA
Wang, Y., Li, O., Li, N., Sha, Z., Zhao, Z., & Xu, J. (2023). Association between the BDNF Val66Met polymorphism and major depressive disorder: a systematic review and meta-analysis. Frontiers in Psychiatry, 14. https://doi.org/10.3389/fpsyt.2023.1143833
Vancouver
Wang Y, Li O, Li N, Sha Z, Zhao Z, Xu J. Association between the BDNF Val66Met polymorphism and major depressive disorder: a systematic review and meta-analysis. Frontiers in Psychiatry. 2023;14. doi:10.3389/fpsyt.2023.1143833
BibTeX
@article{Wang2023,
author = {Wang, Yuxia and Li, Ou and Li, Nana and Sha, Zhongwei and Zhao, Zhenghao and Xu, Jian},
title = {Association between the BDNF Val66Met polymorphism and major depressive disorder: a systematic review and meta-analysis},
journal = {Frontiers in Psychiatry},
year = {2023},
volume = {14},
doi = {10.3389/fpsyt.2023.1143833}
}
EUVIMED